Skip to main content
Medinice S.A. logo

Medinice S.A. — Investor Relations & Filings

Ticker · ICE ISIN · PLMDNCE00016 LEI · 259400LGO9UDV1Y18Z11 WAR Manufacturing
Open in API
Filings indexed 771 across all filing types
Latest filing 2021-04-30 M&A Activity
Country PL Poland
Listing WAR ICE

About Medinice S.A.

https://www.medinice.pl/?lang=2

Medinice S.A. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions in the fields of cardiology and cardiac surgery. The company's mission is to create patient-focused technologies that improve the quality of life for individuals with cardiac diseases. Its portfolio consists of advanced medical devices, including Class III devices, which undergo a full research, development, and clinical trial process before market introduction. Key projects include CoolCryo, a cryoablation system; AtriClamp, for left atrial appendage closure; and PacePress, a specialized compression band used after cardiac device implantation procedures.

Recent filings

Filing Released Lang Actions
Zmiana terminu zawarcia przyrzeczonej umowy przejęcia udziałów w Spółce posiadającej prawa do opatentowanej technologii kardiochirurgicznej - Content (PL)
M&A Activity Classification · 95% confidence The document text discusses an update regarding a preliminary agreement to purchase shares in a company holding patented cardiothoracic technology. It specifically mentions extending the deadline for the final agreement ('Data Zamknięcia') and the completion of due diligence. This content relates directly to a potential acquisition or major transaction involving the company's assets or structure. This aligns best with the Merger & Acquisition Activity (TAR) definition, which covers merger proposals or takeover bids, as this is an update on a significant transaction process.
2021-04-30 Polish
Otrzymanie ochrony patentowej od koreańskiego urzędu patentowego na wynalazek „CoolCryo” - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is a short announcement from the Management Board (Zarząd) of Medinice S.A. regarding their subsidiary receiving notification of a patent grant from the Korean Intellectual Property Office for a medical device ('CoolCryo'). This concerns intellectual property and technological development, which is not explicitly covered by the primary definitions like 10-K, ER, or DIV. It is a specific announcement about a legal/IP development. Since there is no specific code for 'Patent Grant Notification' and it is not a general regulatory filing (RNS) or a legal proceeding report (LTR), it must be evaluated against the provided list. The closest fit, given that it relates to a significant legal/IP asset acquisition, is often grouped under general corporate information or regulatory updates. However, none of the codes perfectly match 'Patent Grant'. Given the context of corporate announcements that don't fit elsewhere, RNS (Regulatory Filings) is the most appropriate fallback for specific, non-financial, non-management change announcements that are material disclosures.
2021-04-23 Polish
Sprawozdanie z badania Medinice S.A.
Audit Report / Information Classification · 99% confidence The document is titled "SPRAWOZDANIE NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z BADANIA" (Independent Auditor's Report on the Audit) and specifically mentions the audit of the annual financial statements ("Sprawozdanie z badania rocznego sprawozdania finansowego") for the period ending December 31, 2020. It contains the auditor's opinion, the basis for the opinion, and details about key audit matters, which are hallmarks of an Audit Report. Although it relates to the annual period, the document itself is the formal report issued by the external auditor, not the full Annual Report (10-K) which is filed by the company management. Therefore, the most appropriate classification is Audit Report / Information (AR). The document length is substantial (over 22k characters), confirming it is the report itself, not just an announcement (RPA/RNS). FY 2020
2021-04-20 Polish
Oświadczenia Rady Nadzroczej Medinice S.A.
Audit Report / Information Classification · 98% confidence The document is titled 'Oświadczenia Rady Nadzorczej do Sprawozdania Finansowego' (Statements of the Supervisory Board on the Financial Statements) and contains detailed assessments and confirmations from the Supervisory Board regarding the compliance, accuracy, and fairness of the company's financial statements and management report for the year 2020. This content strongly aligns with the responsibilities outlined for an Audit Report or general Audit Information, specifically focusing on the board's review and approval process concerning the financial audit results. While it relates to the Annual Report (10-K), this specific document is the formal declaration/assessment by the board, which fits best under 'Audit Report / Information' (AR) as it details the review of the audit and financial statements, rather than being the full annual report itself or a general governance document (CGR). The length (5292 chars) suggests it is a substantive report section, not just a brief announcement (RPA/RNS). FY 2020
2021-04-20 Polish
Oświadczenia i Inofmracja Zarządu Medinice S.A.
Management Reports Classification · 99% confidence The document text consists of formal declarations ('Oświadczenia Zarządu') by the Management Board ('Zarząd') regarding the reliability and compliance of the Financial Statement ('Sprawozdanie Finansowe') for the year ended December 31, 2020, and the Management Report ('Sprawozdanie z Działalności'). It also includes information about the selection and procedure for choosing the auditing firm. These statements are mandatory components typically found within a comprehensive annual filing, such as a 10-K or a full Annual Report package, confirming the integrity of the underlying financial data and management's accountability. Since the content is the formal declaration *accompanying* the full annual results rather than the results themselves (ER) or the full annual report (10-K), and it specifically addresses the audit process and financial statement integrity, it strongly aligns with the scope of an Audit Report/Information (AR) or a component of the Annual Report (10-K). Given the explicit focus on the financial statement certification and auditor confirmation, 'AR' (Audit Report / Information) is the most precise fit among the provided options for this specific set of declarations, although it is often bundled into a 10-K. However, since it is not the full 10-K document, and it heavily features audit-related confirmations, AR is selected.
2021-04-20 Polish
Sprawozdanie Zarządu Medinice S.A.
Management Reports Classification · 99% confidence The document is titled "Sprawozdanie Zarządu z działalności Medinice S.A. za rok 2020" (Management Board Report on the activities of Medinice S.A. for the year 2020) and contains a detailed Table of Contents covering general information, economic/financial performance, strategy, risk factors, corporate governance statements, legal proceedings, product information, and additional information related to financial management and compensation. This structure is characteristic of a comprehensive annual report detailing the company's operations and financial standing for the full fiscal year. Although the title is in Polish, the content strongly aligns with the scope of a 10-K (Annual Report), which covers the entire year's activities and financial results, rather than just an earnings release (ER) or an interim report (IR). Given the comprehensive nature and the reference to the full year 2020, the classification is Annual Report (10-K).
2021-04-20 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.